<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01658072</url>
  </required_header>
  <id_info>
    <org_study_id>11139</org_study_id>
    <nct_id>NCT01658072</nct_id>
  </id_info>
  <brief_title>Analgesia After Total Hip Arthroplasty: Peri-Articular Injection Versus Epidural Patient Controlled Analgesia (PCA)</brief_title>
  <acronym>PAI Hip</acronym>
  <official_title>Analgesia After Total Hip Arthroplasty: Peri-Articular Injection Versus Epidural Patient Controlled Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The best way to provide analgesia after total hip arthroplasty is hotly debated. There are
      two protocols in use at Hospital for Special Surgery(HSS). Both protocols have their
      proponents, but there are limited data for making an informed choice of protocols. For total
      hip arthroplasty at HSS, epidural analgesia is used most frequently as it reduces pain with
      physical therapy. However, epidural analgesia can be associated with nausea, pruritis,
      dizziness, and orthostatic hypotension. These side-effects can slow physical therapy and may
      prolong the time until the patient is ready for discharge. Some surgeons at HSS have decided
      to use a different analgesic protocol, based on a peri-articular injection. This protocol
      avoids epidural analgesia and systemic opioids. However, patients are given oral opioids as
      part of a multimodal pain therapy. The investigators propose to compare peri-articular
      injection to epidural patient controlled analgesia (Epidural PCA). The investigators will
      enroll 90 total patients (45 per study arm). The enrollment period will be approximately one
      year and the duration of the follow-up with study patients will be three months following
      their procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Until Patient is Ready for Discharge</measure>
    <time_frame>Length of Hospital Stay, an expected average of 3 days</time_frame>
    <description>&quot;readiness for discharge&quot; to home or to a rehabilitation facility (compared to the HSS standard regimen of epidural analgesia) after total hip arthroplasty.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Peri-Articular Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural Patient Controlled Analgesia (Epidural PCA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Peri-Articular Injection</intervention_name>
    <description>Use of a different analgesic protocol, based on a peri-articular injection</description>
    <arm_group_label>Peri-Articular Injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural Patient Controlled Analgesia (Epidural PCA)</intervention_name>
    <description>Epidural analgesia pathway.</description>
    <arm_group_label>Epidural Patient Controlled Analgesia (Epidural PCA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with osteoarthritis scheduled for primary total hip arthroplasty with a
             participating surgeon

          -  Age 50 to 80 years old

          -  Planned use of regional anesthesia

          -  Ability to follow study protocol

        Exclusion Criteria:

          -  Patients younger than 50 years old and older than 80

          -  Patients intending to receive general anesthesia

          -  Allergy or intolerance to one of the study medications

          -  Patients with an ASA of IV

          -  Patients with insulin-dependent diabetes

          -  Patients with hepatic (liver) failure

          -  Patients with chronic renal (kidney) failure

          -  Chronic opioid use (taking opioids for longer than 3 months)

          -  Patients with any prior major ipsilateral hip surgery

          -  Allergy to any of the medications (or adhesives) involved in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kethy M Jules-Elysee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2012</study_first_submitted>
  <study_first_submitted_qc>August 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2012</study_first_posted>
  <results_first_submitted>April 4, 2016</results_first_submitted>
  <results_first_submitted_qc>April 4, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 10, 2016</results_first_posted>
  <last_update_submitted>April 4, 2016</last_update_submitted>
  <last_update_submitted_qc>April 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total Hip Arthroplasty</keyword>
  <keyword>Total Hip Replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Peri-Articular Injection</title>
          <description>Peri-Articular Injection: Use of a different analgesic protocol, based on a peri-articular injection</description>
        </group>
        <group group_id="P2">
          <title>Epidural Patient Controlled Analgesia (Epidural PCA)</title>
          <description>Epidural Patient Controlled Analgesia (Epidural PCA): Epidural analgesia pathway.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Peri-Articular Injection</title>
          <description>Peri-Articular Injection: Use of a different analgesic protocol, based on a peri-articular injection</description>
        </group>
        <group group_id="B2">
          <title>Epidural Patient Controlled Analgesia (Epidural PCA)</title>
          <description>Epidural Patient Controlled Analgesia (Epidural PCA): Epidural analgesia pathway.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="41"/>
            <count group_id="B2" value="43"/>
            <count group_id="B3" value="84"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.7" spread="8.5"/>
                    <measurement group_id="B2" value="64.8" spread="7.1"/>
                    <measurement group_id="B3" value="64.3" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/(m^2)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.0" spread="5.4"/>
                    <measurement group_id="B2" value="27.9" spread="6.2"/>
                    <measurement group_id="B3" value="28.0" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time Until Patient is Ready for Discharge</title>
        <description>&quot;readiness for discharge&quot; to home or to a rehabilitation facility (compared to the HSS standard regimen of epidural analgesia) after total hip arthroplasty.</description>
        <time_frame>Length of Hospital Stay, an expected average of 3 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peri-Articular Injection</title>
            <description>Peri-Articular Injection: Use of a different analgesic protocol, based on a peri-articular injection</description>
          </group>
          <group group_id="O2">
            <title>Epidural Patient Controlled Analgesia (Epidural PCA)</title>
            <description>Epidural Patient Controlled Analgesia (Epidural PCA): Epidural analgesia pathway.</description>
          </group>
        </group_list>
        <measure>
          <title>Time Until Patient is Ready for Discharge</title>
          <description>&quot;readiness for discharge&quot; to home or to a rehabilitation facility (compared to the HSS standard regimen of epidural analgesia) after total hip arthroplasty.</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.7"/>
                    <measurement group_id="O2" value="2.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Peri-Articular Injection</title>
          <description>Peri-Articular Injection: Use of a different analgesic protocol, based on a peri-articular injection</description>
        </group>
        <group group_id="E2">
          <title>Epidural Patient Controlled Analgesia (Epidural PCA)</title>
          <description>Epidural Patient Controlled Analgesia (Epidural PCA): Epidural analgesia pathway.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kethy Jules-Elysee, MD</name_or_title>
      <organization>Hospital for Special Surgery</organization>
      <phone>2126061206</phone>
      <email>juleselyseek@hss.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

